ASEPA NEWS

ASEPA NEWSLETTERS

 

January 2021 Newsletter

July 2020 Newsletter

January 2020 Newsletter
July 2019 Newsletter

January 2019 Newsletter

 
 

RECENT NEWS

 

October 11, 2020: 

Highlight of new Freestyle Libre 2 Flash CGM on Danatech 

https://www.danatech.org/continuous-glucose-meters/freestyle-libre-2-flash-glucose-monitoring-system/

** If this link takes you to the danatech login page instead of opening directly, enter your username and password; your browser will then automatically be directed to the above link.

June 18, 2020: 

FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev

https://www.medscape.com/viewarticle/932572?nlid=136000_3901&src=wnl_newsalrt_200618_MSCPEDIT&uac=151802MX&impID=2424955&faf=1

June 17, 2020: 

The following poster was presented virtually at the ADA 80th Scientific Sessions held June 12-16, 2020 

The Case for Targeted Diabetes Medication and Device CME for PCPs 

June 17, 2020: 

The following article was published in Diabetes Research and Clinical Practice 

Enhancing resources for healthcare professionals caring for people on intensive insulin therapy: Summary from a national workshop

 

March 24, 2020: 

AACE Position Statement: Coronavirus (COVID-19) and People with Adrenal Insufficiency and Cushing’s Syndrome

https://www.aace.com/recent-news-and-updates/aace-position-statement-coronavirus-covid-19-and-people-adrenal

 

March 9, 2020: 

FDA draft guidance eliminates CV outcomes trial recommendation for diabetes drug approvals

https://www.healio.com/endocrinology/cardiometabolic-disorders/news/online/%7B776cceaa-906d-4ecc-a8ea-e7479c3de9ba%7D/fda-draft-guidance-eliminates-cv-outcomes-trial-recommendation-for-diabetes-drug-approvals

February 15, 2020: 

FDA recall on Medtronic pumps - 600 series

https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-minimed-insulin-pumps-incorrect-insulin-dosing

February 13, 2020:

FDA voluntary recall of anti-obesity drug Belviq

https://www.fda.gov/safety/medical-product-safety-information/belviq-belviq-xr-lorcaserin-eisai-drug-safety-communication-fda-requests-withdrawal-weight-loss-drug

January 28, 2020:

FDA okays triple-combo pill for type 2 diabetes

https://www.mdedge.com/endocrinology/article/216254/diabetes/fda-okays-triple-combo-pill-type-2-diabetes

January 21, 2020: 

FDA approves first treatment for thyroid eye disease 

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-thyroid-eye-disease

 

January 16, 2020:

FDA Approves Semaglutide Injection for Cardiovascular Risk Reduction

https://www.mdmag.com/medical-news/fda-semaglutide-injection-ozempic-cardiovascular-reduction

January 6, 2020:

Fiasp is now approved for children with diabetes

https://www.healio.com/endocrinology/diabetes/news/online/%7B4fc7dab7-a67b-4e15-84ac-f534bbc2b3ca%7D/fda-approves-rapid-acting-insulin-for-children-with-diabetes

 

December 13, 2019:

FDA approves Tandem Diabetes Care Control IQ Technology, a integrated insulin pump + continuous glucose sensor

https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices

 

October 22, 2019: 
FDA OKs Faster-Acting Insulin Aspart for Pump Use (Fiasp)

medscape.com/viewarticle/920162

 

October 21, 2019: 
FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes (Farxiga)

medscape.com/viewarticle/920093

 

September 30, 2019: 
FDA OKs Canagliflozin to Curtail Diabetic Kidney Disease (Invokana)

medscape.com/viewarticle/919184

 

 

CMHC’s Monthly Newsletter:
cardiometabolichealth.org/newsletter.html

MEETINGS

 

ASEPA members meet twice a year at the following conferences: AAPA and AACE. We also meet informally at the MEDS East and MEDS West conferences.

 

Throughout the year, board members communicate frequently via email and conference calls.